← Back
Data updated: Mar 10, 2026
MCPRF
Oncology
MCPRF is a pharmaceutical company focused on Oncology. Key products include CHOLINE C-11.
2012
Since
4
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
AMMONIA N 13 2026-02-13
Manufacturing (CMC)
FLUDEOXYGLUCOSE F18 2025-03-11
CHOLINE C-11 2024-09-09
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (0)
Company Info
- First Approval
- 2012-09-12
- Latest
- 2024-09-09
- Applications
- 4